SPYRE THERAPEUTICS, INC. Other Income and Expense
SPYRE THERAPEUTICS, INC. (SYRE) reported Other Income and Expense of $5.44 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Income Statement › Other Income
us-gaap:NonoperatingIncomeExpense · last filed 2026-08-04
- SPYRE THERAPEUTICS, INC. nonoperating income (expense) for the quarter ending 2026-06-30 was $5.44M, a 4.24% increase year-over-year.
- SPYRE THERAPEUTICS, INC. nonoperating income (expense) for the quarter ending 2026-03-31 was -$23.36M, a 366.14% decline year-over-year.
- SPYRE THERAPEUTICS, INC. nonoperating income (expense) for the quarter ending 2025-12-31 was -$5.36M, a 208.07% decline year-over-year.
- SPYRE THERAPEUTICS, INC. nonoperating income (expense) for the quarter ending 2025-09-30 was $45.70M.
- SPYRE THERAPEUTICS, INC. nonoperating income (expense) for fiscal 2025 was $54.34M, a 8972.45% increase from fiscal 2024.
- SPYRE THERAPEUTICS, INC. nonoperating income (expense) for fiscal 2024 was $599.00K.
- SPYRE THERAPEUTICS, INC. nonoperating income (expense) for fiscal 2023 was -$96.51M, a 11728.07% decline from fiscal 2022.
- SPYRE THERAPEUTICS, INC. nonoperating income (expense) for fiscal 2022 was $830.00K.
| Period end | Nonoperating Income (Expense) 3 month | Nonoperating Income (Expense) 6 month | Nonoperating Income (Expense) 9 month | Nonoperating Income (Expense) 12 month |
|---|---|---|---|---|
| 2026-06-30 | $5.44M 10-Q · filed 2026-08-04 | -$17.93M 10-Q · filed 2026-08-04 | -$23.28M derived: sum of 3 quarters · filed 2026-08-04 | $22.42M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | -$23.36M 10-Q · filed 2026-05-05 | -$28.72M derived: sum of 2 quarters · filed 2026-05-05 | $16.98M derived: sum of 3 quarters · filed 2026-05-05 | $22.20M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | -$5.36M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $40.35M derived: sum of 2 quarters · filed 2026-02-19 | $45.56M derived: sum of 3 quarters · filed 2026-08-04 | $54.34M 10-K · filed 2026-02-19 |
| 2025-09-30 | $45.70M 10-Q · filed 2025-11-04 | $50.92M derived: sum of 2 quarters · filed 2026-08-04 | $59.70M 10-Q · filed 2025-11-04 | $64.66M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $5.22M 10-Q · filed 2026-08-04 | $14.00M 10-Q · filed 2026-08-04 | $18.95M derived: sum of 3 quarters · filed 2026-08-04 | $5.34M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $8.78M 10-Q · filed 2026-05-05 | $13.74M derived: sum of 2 quarters · filed 2026-05-05 | $119.00K derived: sum of 3 quarters · filed 2026-05-05 | $5.43M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $4.96M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | -$8.66M derived: sum of 2 quarters · filed 2026-02-19 | -$3.35M derived: sum of 3 quarters · filed 2026-02-19 | $599.00K 10-K · filed 2026-02-19 |
| 2024-09-30 | -$13.62M 10-Q · filed 2025-11-04 | -$8.31M derived: sum of 2 quarters · filed 2025-11-04 | -$4.36M 10-Q · filed 2025-11-04 | -$21.63M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-06-30 | $5.31M 10-Q · filed 2025-08-05 | $9.26M 10-Q · filed 2025-08-05 | -$8.01M derived: sum of 3 quarters · filed 2026-02-19 | -$29.77M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-03-31 | $3.95M 10-Q · filed 2025-05-08 | -$13.32M derived: sum of 2 quarters · filed 2026-02-19 | -$35.08M derived: sum of 3 quarters · filed 2026-02-19 | -$92.91M derived: sum of 4 quarters · filed 2026-02-19 |
| 2023-12-31 | -$17.27M derived: 10-K 12 month − 10-Q/A 9 month · filed 2026-02-19 | -$39.03M derived: sum of 2 quarters · filed 2026-02-19 | -$96.86M derived: sum of 3 quarters · filed 2026-02-19 | -$96.51M 10-K · filed 2026-02-19 |
| 2023-09-30 | -$21.77M 10-Q/A · filed 2024-11-18 | -$79.59M derived: sum of 2 quarters · filed 2024-11-18 | -$79.25M 10-Q/A · filed 2024-11-18 | -$78.87M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | -$57.83M 10-Q/A · filed 2024-11-18 | -$57.48M 10-Q/A · filed 2024-11-18 | -$57.10M derived: sum of 3 quarters · filed 2025-02-27 | -$56.79M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $348.00K 10-Q/A · filed 2024-11-18 | $726.00K derived: sum of 2 quarters · filed 2025-02-27 | $1.04M derived: sum of 3 quarters · filed 2025-02-27 | $1.15M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $378.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $690.00K derived: sum of 2 quarters · filed 2025-02-27 | $799.00K derived: sum of 3 quarters · filed 2025-02-27 | $830.00K 10-K · filed 2025-02-27 |
| 2022-09-30 | $312.00K 10-Q · filed 2023-11-09 | $421.00K derived: sum of 2 quarters · filed 2023-11-09 | $452.00K 10-Q · filed 2023-11-09 | $445.00K derived: sum of 4 quarters · filed 2024-11-18 |
| 2022-06-30 | $109.00K 10-Q · filed 2023-08-11 | $140.00K 10-Q · filed 2023-08-11 | $133.00K derived: sum of 3 quarters · filed 2024-11-18 | $145.00K derived: sum of 4 quarters · filed 2024-11-18 |
| 2022-03-31 | $5.00K 10-Q · filed 2023-05-11 | $24.00K derived: sum of 2 quarters · filed 2024-11-18 | $36.00K derived: sum of 3 quarters · filed 2024-11-18 | $3.00K derived: sum of 4 quarters · filed 2024-11-18 |
| 2021-12-31 | $19.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-11-18 | $31.00K derived: sum of 2 quarters · filed 2024-11-18 | -$2.00K derived: sum of 3 quarters · filed 2024-11-18 | -$11.00K 10-K/A · filed 2024-11-18 |
| 2021-09-30 | $12.00K 10-Q · filed 2022-11-03 | -$21.00K derived: sum of 2 quarters · filed 2022-11-03 | -$30.00K 10-Q · filed 2022-11-03 | $32.00K derived: sum of 4 quarters · filed 2023-03-02 |
| 2021-06-30 | -$33.00K 10-Q · filed 2022-08-04 | -$42.00K 10-Q · filed 2022-08-04 | $20.00K derived: sum of 3 quarters · filed 2023-03-02 | $110.00K derived: sum of 4 quarters · filed 2023-03-02 |
| 2021-03-31 | -$9.00K 10-Q · filed 2022-05-05 | $53.00K derived: sum of 2 quarters · filed 2023-03-02 | $143.00K derived: sum of 3 quarters · filed 2023-03-02 | $285.00K derived: sum of 4 quarters · filed 2023-03-02 |
| 2020-12-31 | $62.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | $152.00K derived: sum of 2 quarters · filed 2023-03-02 | $294.00K derived: sum of 3 quarters · filed 2023-03-02 | $588.00K 10-K · filed 2023-03-02 |
| 2020-09-30 | $90.00K 10-Q · filed 2021-11-04 | $232.00K derived: sum of 2 quarters · filed 2021-11-04 | $526.00K 10-Q · filed 2021-11-04 | $940.00K derived: sum of 4 quarters · filed 2022-03-08 |
| 2020-06-30 | $142.00K 10-Q · filed 2021-08-05 | $436.00K 10-Q · filed 2021-08-05 | $850.00K derived: sum of 3 quarters · filed 2022-03-08 | $1.42M derived: sum of 4 quarters · filed 2022-03-08 |
| 2020-03-31 | $294.00K 10-Q · filed 2021-05-10 | $708.00K derived: sum of 2 quarters · filed 2022-03-08 | $1.28M derived: sum of 3 quarters · filed 2022-03-08 | $1.88M derived: sum of 4 quarters · filed 2022-03-08 |
| 2019-12-31 | $414.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08 | $987.00K derived: sum of 2 quarters · filed 2022-03-08 | $1.59M derived: sum of 3 quarters · filed 2022-03-08 | $2.08M 10-K · filed 2022-03-08 |
| 2019-09-30 | $573.00K 10-Q · filed 2020-11-05 | $1.18M derived: sum of 2 quarters · filed 2020-11-05 | $1.67M 10-Q · filed 2020-11-05 | $2.07M derived: sum of 4 quarters · filed 2021-03-18 |
| 2019-06-30 | $603.00K 10-Q · filed 2020-08-10 | $1.09M 10-Q · filed 2020-08-10 | $1.50M derived: sum of 3 quarters · filed 2021-03-18 | $1.83M derived: sum of 4 quarters · filed 2021-03-18 |
| 2019-03-31 | $490.00K 10-Q · filed 2020-05-07 | $897.00K derived: sum of 2 quarters · filed 2021-03-18 | $1.22M derived: sum of 3 quarters · filed 2021-03-18 | $1.48M derived: sum of 4 quarters · filed 2021-03-18 |
| 2018-12-31 | $407.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | $733.00K derived: sum of 2 quarters · filed 2021-03-18 | $989.00K derived: sum of 3 quarters · filed 2021-03-18 | $1.11M 10-K · filed 2021-03-18 |
| 2018-09-30 | $326.00K 10-Q · filed 2019-11-06 | $582.00K derived: sum of 2 quarters · filed 2019-11-06 | $708.00K 10-Q · filed 2019-11-06 | $851.00K derived: sum of 4 quarters · filed 2020-02-24 |
| 2018-06-30 | $256.00K 10-Q · filed 2019-08-06 | $382.00K 10-Q · filed 2019-08-06 | $525.00K derived: sum of 3 quarters · filed 2020-02-24 | $649.00K derived: sum of 4 quarters · filed 2020-02-24 |
| 2018-03-31 | $126.00K 10-Q · filed 2019-05-07 | $269.00K derived: sum of 2 quarters · filed 2020-02-24 | $393.00K derived: sum of 3 quarters · filed 2020-02-24 | $481.00K derived: sum of 4 quarters · filed 2020-02-24 |
| 2017-12-31 | $143.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24 | $267.00K derived: sum of 2 quarters · filed 2020-02-24 | $355.00K derived: sum of 3 quarters · filed 2020-02-24 | $440.00K 10-K · filed 2020-02-24 |
| 2017-09-30 | $124.00K 10-Q · filed 2018-11-08 | $212.00K derived: sum of 2 quarters · filed 2018-11-08 | $297.00K 10-Q · filed 2018-11-08 | $356.00K derived: sum of 4 quarters · filed 2019-03-07 |
| 2017-06-30 | $88.00K 10-Q · filed 2018-08-09 | $172.00K 10-Q · filed 2018-08-09 | $232.00K derived: sum of 3 quarters · filed 2019-03-07 | $295.00K derived: sum of 4 quarters · filed 2019-03-07 |
| 2017-03-31 | $84.00K 10-Q · filed 2018-05-08 | $144.00K derived: sum of 2 quarters · filed 2019-03-07 | $207.00K derived: sum of 3 quarters · filed 2019-03-07 | $272.00K derived: sum of 4 quarters · filed 2019-03-07 |
| 2016-12-31 | $60.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | $123.00K derived: sum of 2 quarters · filed 2019-03-07 | $188.00K derived: sum of 3 quarters · filed 2019-03-07 | $208.00K 10-K · filed 2019-03-07 |
| 2016-09-30 | $63.00K 10-Q · filed 2017-11-07 | $128.00K derived: sum of 2 quarters · filed 2017-11-07 | $148.00K 10-Q · filed 2017-11-07 | $158.00K derived: sum of 4 quarters · filed 2018-03-13 |
| 2016-06-30 | $65.00K 10-Q · filed 2017-08-09 | $85.00K 10-Q · filed 2017-08-09 | $95.00K derived: sum of 3 quarters · filed 2018-03-13 | $99.00K derived: sum of 4 quarters · filed 2018-03-13 |
| 2016-03-31 | $20.00K 10-Q · filed 2017-05-09 | $30.00K derived: sum of 2 quarters · filed 2018-03-13 | $34.00K derived: sum of 3 quarters · filed 2018-03-13 | $39.00K derived: sum of 4 quarters · filed 2018-03-13 |
| 2015-12-31 | $10.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-13 | $14.00K derived: sum of 2 quarters · filed 2018-03-13 | $19.00K derived: sum of 3 quarters · filed 2018-03-13 | $20.00K 10-K · filed 2018-03-13 |
| 2015-09-30 | $4.00K 10-Q · filed 2016-11-09 | $9.00K derived: sum of 2 quarters · filed 2016-11-09 | $10.00K 10-Q · filed 2016-11-09 | |
| 2015-06-30 | $5.00K 10-Q · filed 2016-08-09 | $6.00K 10-Q · filed 2016-08-09 | ||
| 2015-03-31 | $1.00K 10-Q · filed 2016-05-19 | |||
| 2014-12-31 | -$1.44M 10-K · filed 2017-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |